## Abstract The objective of this study was to examine the relationship between CAG repeat length (CAGn) and clinical progression in patients with Huntington's disease (HD). There are conflicting reports about the relationship between CAGn and clinical progression of HD. We conducted an analysis of
The relationship between uric acid levels and Huntington's disease progression
β Scribed by Peggy Auinger; Karl Kieburtz; Michael P. Mcdermott
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 553 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Uric acid (UA) may be associated with the progression of Parkinson's disease and related neurodegenerative conditions; however, its association with Huntington's disease (HD) progression has not been explored. A secondary analysis of 347 subjects from the CAREβHD clinical trial was performed to examine the relationship between baseline UA levels and the level of functional decline in HD. Outcomes included change in scores at 30 months for the Unified Huntington's Disease Rating Scale components. There was less worsening of total functional capacity over time with increasing baseline UA levels (adjusted mean worsening in scores: 3.17, 2.99, 2.95, 2.28, 2.21, from lowest to highest UA quintile, P = 0.03). These data suggest a possible association between higher UA levels and slower HD progression, particularly as measured by total functional capacity. If confirmed, UA could be an important predictor and potentially modifiable factor affecting the rate of HD progression. Β© 2009 Movement Disorder Society
π SIMILAR VOLUMES
Elevated serum uric acid (UA) levels strongly reflect and may even cause oxidative stress, insulin resistance, and metabolic syndrome, which are risk factors for the progression of liver disease. We sought to determine whether serum UA levels are associated with the development of cirrhosis or the p
be related to a lysosomal storage disorder. However, they were unable to identify a specific lysosomal enzyme abnormality. In summary, we have described the pathological features of muscle biopsy specimens from 3 infantile cases of Marinesco-S jogren syndrome. W e have identified an unusual ultrast